Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Novel methyl and ethyl protection strategy improves yield and stability for Telmisartan manufacturing, offering significant cost and supply chain advantages.
Patent CN101270091A details a clean hydrazine reduction and zinc chloride separation method for high-purity albendazole intermediates.
Novel acidic synthesis method for nicardipine hydrochloride ensures high purity and scalable industrial production for global pharmaceutical supply chains reducing environmental impact significantly.
Novel two-step synthesis patent CN113045416B ensures high yield and purity. Ideal for reliable pharmaceutical intermediates supplier partnerships seeking cost reduction.
Novel continuous flow photo-thermal synthesis method ensures high purity and scalable production for pharmaceutical intermediates reducing lead time significantly.
Advanced proline-assisted crystallization for high-purity Doripenem. Enhancing stability and yield in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN103664537B enables high-yield resveratrol production. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain continuity.
Patent CN117430521A reveals Lewis acid catalysis for Glupa-C. Enhances purity and safety for reliable pharmaceutical intermediates supplier operations.
Novel patent CN104650160A offers high yield 1,2,3-O-triacetyl-5-deoxy-D-ribose synthesis. Ensures supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel enzyme catalytic system synthesizes organic selenides greenly. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing without heavy metals.
Patent CN102702204A details a high-yield synthesis of Tebipenem Pivoxil using iodide catalysis, offering significant cost reduction and purity improvements for pharmaceutical manufacturers.
Patent CN105330554B reveals a safer synthesis for Efavirenz intermediates. Achieve high ee values and cost reduction in API manufacturing with scalable zinc chemistry.
Advanced patent-based synthesis of cinacalcet intermediate offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN112608317A reveals a novel Sildenafil synthesis route using Zinc reduction and Thionyl Chloride activation, offering significant cost reduction and scalability for API manufacturing.
Novel aspartic acid route offers high purity and cost efficiency for quinolone antibiotic intermediates, ensuring reliable supply chain stability.
Patent CN114031542A reveals a green Cu-catalyzed cyclization route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel synthesis route for azelastine intermediate offers high yield and cost reduction. Reliable supply chain for pharmaceutical intermediates manufacturing.
Patent CN113336791A details a novel ZSM-5 supported catalyst method for Fosfomycin Calcium, offering higher yields and reduced heavy metal residues for antibiotic manufacturing.
Patent CN112679290B reveals a cost-effective nickel-catalyzed asymmetric hydroalkynylation for AMG 837 intermediates, offering superior enantioselectivity and mild conditions.